{"success":true,"data":{"pressRelease":{"id":"49344","rtpr_id":"nGNX5crt2p","ticker":"IMMP","exchange":"NASDAQ","all_tickers":["IMMP","IMM"],"title":"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 6, 2026 in Immutep Limited Lawsuit - IMMP","author":"Globe Newswire","published_at":"2026-05-29T13:00:00.351Z","article_body":"NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the\nfollowing notice to shareholders of Immutep Limited (NASDAQ: IMMP).\n\nShareholders who purchased shares of IMMP during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointment.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCONTACT US HERE:\n\nhttps://securitiesclasslaw.com/securities/immutep-limited-loss-submission-form/?id=187150&from=3\n\nCLASS PERIOD: March 24, 2025 to March 12, 2026\n\nALLEGATIONS: According to the complaint, defendants provided overwhelmingly\npositive statements to investors while, at the same time, disseminating false\nand misleading statements and/or concealing material adverse facts concerning\nthe efficacy and safety of its TACTI-004 Phase III clinical trial study. On\nMarch 13, 2026, Immutep issued a press release announcing that the Independent\nData Monitoring (IDMC) for the TACTI-004 Phase III study recommended that the\ntrial be discontinued following a planned interim futility analysis. Further,\nbased on its review of the available safety and efficacy data, the IDMC\nrecommended that the trial be discontinued for futility. Following this news,\nthe price of Immutep’s ADRs declined dramatically. From a closing market\nprice of $2.76 per share on March 12, 2026, Immutep’s stock price fell to\n$0.48 per share on March 13, 2026, a decline of about 83%.\n\nDEADLINE: July 6, 2026 Shareholders should not delay in registering for this\nclass action. Register your information here:\nhttps://securitiesclasslaw.com/securities/immutep-limited-loss-submission-form/?id=187150&from=3\n\nNEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased\nshares of IMMP during the timeframe listed above, you will be enrolled in a\nportfolio monitoring software to provide you with status updates throughout\nthe lifecycle of the case. The deadline to seek to be a lead plaintiff is July\n6, 2026. There is no cost or obligation to you to participate in this case.\n\nWHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action\nlaw firm, and our mission is to protect the rights of all investors who have\nsuffered as a result of deceit, fraud, and illegal business practices. The\nGross Law Firm is committed to ensuring that companies adhere to responsible\nbusiness practices and engage in good corporate citizenship. The firm seeks\nrecovery on behalf of investors who incurred losses when false and/or\nmisleading statements or the omission of material information by a company\nlead to artificial inflation of the company's stock. Attorney advertising.\nPrior results do not guarantee similar outcomes.\n\nCONTACT:\nThe Gross Law Firm\n15 West 38th Street, 12th floor\nNew York, NY, 10018\nEmail: dg@securitiesclasslaw.com\nPhone: (646) 453-8903\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/0e447323-403e-415d-a0b4-846f2654a80f)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX5crt2p","title":"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 6, 2026 in Immutep Limited Lawsuit - IMMP","author":"Globe Newswire","ticker":"IMMP","created":"2026-05-29T13:00:00.351Z","tickers":["IMMP","IMM"],"exchange":"NASDAQ","article_body":"NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the\nfollowing notice to shareholders of Immutep Limited (NASDAQ: IMMP).\n\nShareholders who purchased shares of IMMP during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointment.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCONTACT US HERE:\n\nhttps://securitiesclasslaw.com/securities/immutep-limited-loss-submission-form/?id=187150&from=3\n\nCLASS PERIOD: March 24, 2025 to March 12, 2026\n\nALLEGATIONS: According to the complaint, defendants provided overwhelmingly\npositive statements to investors while, at the same time, disseminating false\nand misleading statements and/or concealing material adverse facts concerning\nthe efficacy and safety of its TACTI-004 Phase III clinical trial study. On\nMarch 13, 2026, Immutep issued a press release announcing that the Independent\nData Monitoring (IDMC) for the TACTI-004 Phase III study recommended that the\ntrial be discontinued following a planned interim futility analysis. Further,\nbased on its review of the available safety and efficacy data, the IDMC\nrecommended that the trial be discontinued for futility. Following this news,\nthe price of Immutep’s ADRs declined dramatically. From a closing market\nprice of $2.76 per share on March 12, 2026, Immutep’s stock price fell to\n$0.48 per share on March 13, 2026, a decline of about 83%.\n\nDEADLINE: July 6, 2026 Shareholders should not delay in registering for this\nclass action. Register your information here:\nhttps://securitiesclasslaw.com/securities/immutep-limited-loss-submission-form/?id=187150&from=3\n\nNEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased\nshares of IMMP during the timeframe listed above, you will be enrolled in a\nportfolio monitoring software to provide you with status updates throughout\nthe lifecycle of the case. The deadline to seek to be a lead plaintiff is July\n6, 2026. There is no cost or obligation to you to participate in this case.\n\nWHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action\nlaw firm, and our mission is to protect the rights of all investors who have\nsuffered as a result of deceit, fraud, and illegal business practices. The\nGross Law Firm is committed to ensuring that companies adhere to responsible\nbusiness practices and engage in good corporate citizenship. The firm seeks\nrecovery on behalf of investors who incurred losses when false and/or\nmisleading statements or the omission of material information by a company\nlead to artificial inflation of the company's stock. Attorney advertising.\nPrior results do not guarantee similar outcomes.\n\nCONTACT:\nThe Gross Law Firm\n15 West 38th Street, 12th floor\nNew York, NY, 10018\nEmail: dg@securitiesclasslaw.com\nPhone: (646) 453-8903\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/0e447323-403e-415d-a0b4-846f2654a80f)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-05-29T13:00:00.413198943Z","server_sent_at_ms":1780059600413},"received_at":"2026-05-29T13:00:00.503Z","source_url":null},"analysis":{"id":"38775","press_release_id":"49344","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"The Gross Law Firm issued a shareholder-solicitation notice naming Immutep Limited (IMMP); no new disclosure from the company itself.\n\nThe release is a routine lead-plaintiff-deadline reminder soliciting investors with losses to contact the firm on a contingency basis.\n\nThis is law-firm marketing, not an issuer disclosure or a court action; treat as low-signal noise.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"There is no cost or obligation to you to participate in this case.","namedEntities":{"people":[],"products":["TACTI-004"],"companies":[{"name":"The Gross Law Firm","relationship":"plaintiff law firm"},{"name":"Immutep Limited","ticker":"IMMP"}],"dollarAmounts":[{"amount":"$2.76","context":"closing market price on March 12, 2026"},{"amount":"$0.48","context":"stock price on March 13, 2026"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by The Gross Law Firm. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"IMMP"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"The Gross Law Firm issued a shareholder-solicitation notice naming Immutep Limited (IMMP); no new disclosure from the company itself.\n\nThe release is a routine lead-plaintiff-deadline reminder soliciting investors with losses to contact the firm on a contingency basis.\n\nThis is law-firm marketing, not an issuer disclosure or a court action; treat as low-signal noise.","key_figures":{},"named_entities":{"people":[],"products":["TACTI-004"],"companies":[{"name":"The Gross Law Firm","relationship":"plaintiff law firm"},{"name":"Immutep Limited","ticker":"IMMP"}],"dollarAmounts":[{"amount":"$2.76","context":"closing market price on March 12, 2026"},{"amount":"$0.48","context":"stock price on March 13, 2026"}]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-29T13:00:39.606Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":16393,"modelName":"george-droid-qwen-72b"}}